Philippe Halfon

Halfon received a PharmD in 1984 and PhD in 1999 from Aix-Marseille University. He also holds an MD from the University of Medicine of Marseille in 2006^{[citation needed]}. He has previously worked and studied at the associated medical centre at Aix-Marseille University, later working in Infectious Disease in Montreal, Canada.^[2]

He was previously appointed Research Director at Aix-Marseille University and an associate professor at Paris Hospital College.^{[citation needed]} He was also a visiting Professor of Medicine at Emory University, United States^{[citation needed]}, and Hadassah Medical Centre, Israel.^[3][4][5] His research focuses on cancer and virology, including SARS-CoV-2,^[6] and he has published on these topics.^[7]

Halfon is also the co-founder of biomedical sector companies Alphabio Clinical Laboratories,^[8] and Genoscience Pharma, for which he is also the CEO.^[9]